tocilizumab
Showing 1 - 25 of 214
COVID-19 Trial in Chicago (Tocilizumab, Standard of Care)
Recruiting
- COVID-19
- Tocilizumab
- Standard of Care
-
Chicago, IllinoisUniversity of Chicago Medicine
May 11, 2022
Sickle Cell Disease, Acute Chest Syndrome Trial (Tocilizumab)
Not yet recruiting
- Sickle Cell Disease
- Acute Chest Syndrome
- Tocilizumab
- (no location specified)
Nov 28, 2022
Tocilizumab Versus Tocilizumab/Infliximab in COVID-19-associated
Completed
- Covid19
- +2 more
- Tocilizumab
- Infliximab
-
Cairo, Please Select, EgyptTeachers Hospital
Jul 19, 2022
COVID-19 Trial in Patras (Tocilizumab, Baricitinib)
Recruiting
- COVID-19
- Tocilizumab
- Baricitinib
-
Patras, GreeceUniversity Hospital of Patras, Department of Respiratory Medicin
Apr 5, 2022
Hemophagocytic Lymphohistiocytosis Trial in Philadelphia (tocilizumab)
Withdrawn
- Hemophagocytic Lymphohistiocytosis
- tocilizumab
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Mar 11, 2022
Hematologic Malignancy Trial in Milwaukee (Tacrolimus, Methotrexate, Tocilizumab)
Active, not recruiting
- Hematologic Malignancy
- Tacrolimus
- +2 more
-
Milwaukee, WisconsinFroedtert Hospital
Mar 2, 2022
COVID-19 Virus Infection, Cytokine Storm, Corticosteroid Trial (Methylprednisolone, Tocilizumab)
Withdrawn
- COVID-19 Virus Infection
- +3 more
- Methylprednisolone
- Tocilizumab
- (no location specified)
Nov 22, 2021
Breast Cancer Trial in Fayoum (Tocilizumab, traditional Covid -19 therapy)
Recruiting
- Breast Cancer
- Tocilizumab
- traditional Covid -19 therapy
-
Fayoum, EgyptALsafwa specialized hospital
Mar 16, 2022
COVID-19 Trial in New York (Tocilizumab)
Active, not recruiting
- COVID-19
- Tocilizumab
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 21, 2022
Leukemia Trial in Houston (Alemtuzumab, Etoposide, Dexamethasone)
Active, not recruiting
- Leukemia
- Alemtuzumab
- +5 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Feb 2, 2022
Pancreatic Cancer Trial in Herlev (Nivolumab, Ipilimumab, Tocilizumab)
Terminated
- Pancreatic Cancer
- Nivolumab
- +3 more
-
Herlev, DenmarkHerlev & Gentofte University Hospital, Denmark
Mar 15, 2022
Coronavirus Infection, SARS (Severe Acute Respiratory Syndrome), Virus Diseases Trial in Cayenne (Tocilizumab, Dexamethasone)
Completed
- Coronavirus Infection
- +7 more
- Tocilizumab
- Dexamethasone
-
Cayenne, French GuianaCH Andrée Rosemon
Jun 7, 2022
COVID-19 Severe Respiratory Failure Trial in Alexandroupolis (Dexamethasone, Low molecular weight heparin, Anakinra 100Mg/0.67Ml
Recruiting
- COVID-19 Severe Respiratory Failure
- Dexamethasone
- +5 more
-
Alexandroupolis, Evros, GreeceUniversity Hospital of Alexandroupolis
Mar 11, 2022
Unresectable Pancreatic Carcinoma Trial in Herlev, Oslo (Tocilizumab, Gemcitabine, nab-Paclitaxel)
Active, not recruiting
- Unresectable Pancreatic Carcinoma
- Tocilizumab
- +2 more
-
Herlev, Denmark
- +1 more
Mar 15, 2022
Rapid Progressive Interstitial Lung Diseases Trial in Beijing (Tocilizumab)
Recruiting
- Rapid Progressive Interstitial Lung Diseases
- Tocilizumab
-
Beijing, ChinaPeking Union Medical College Hospital
Dec 19, 2021
Covid19 Trial in Ipatinga, Varginha, Aracaju (Tocilizumab, Heparin - Therapeutic dosage, Heparin - Prophylactic dosage)
Completed
- Covid19
- Tocilizumab
- +2 more
-
Ipatinga, Minas Gerais, Brazil
- +2 more
Mar 17, 2022
Coronary Artery Disease, Aortic Valve Disease Trial in Copenhagen (Tocilizumab, Isotonic sodium chloride (0.9%), Dexamethasone
Recruiting
- Coronary Artery Disease
- Aortic Valve Disease
- Tocilizumab
- +8 more
-
Copenhagen, DenmarkThe Heart Centre, Rigshospitalet
Nov 29, 2022
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Atlanta (Tocilizumab, Venetoclax)
Not yet recruiting
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Tocilizumab
- Venetoclax
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Aug 1, 2022
Schizophrenia, Psychotic Disorders Trial in Augusta (Tocilizumab, Normal saline)
Recruiting
- Schizophrenia
- Psychotic Disorders
- Tocilizumab
- Normal saline
-
Augusta, GeorgiaAugusta University
Jul 27, 2021
Tocilizumab, COVID-19, Critical Care Trial in Trabzon (Tocilizumab)
Completed
- Tocilizumab
- +3 more
- Tocilizumab
-
Trabzon, TurkeyKaradeniz Technical University
May 18, 2021
ive Alzheimer's Medicines (DREAM) - Tocilizumab vs Abatacept
Completed
- Rheumatoid Arthritis
- Tocilizumab
- Abatacept
-
Boston, MassachusettsBrigham and Women's Hospital
Nov 15, 2021
Giant Cell Arteritis Trial in Boston (Tocilizumab, Prednisone)
Recruiting
- Giant Cell Arteritis
- Tocilizumab
- Prednisone
-
Boston, MassachusettsMassachusetts General Hospital
Jul 23, 2021
Tocilizumab on Procalcitonin and Other Biochemical and Clinical
Not yet recruiting
- COVID-19 Pneumonia
- ARDS
- Tocilizumab
-
Imsida, MaltaMater Dei Hospital
Sep 2, 2021